New Partners Hunt Breakthroughs for Kids With Rare Brain Disorders
Angelini Pharma and Quiver Bioscience have joined forces to look for new medicines that could help children suffering from hard‑to‑treat genetic epilepsies. The deal gives Quiver a chance to use Angelini’s long experience in brain drugs while Angelini gains access to Quiver’s cutting‑edge AI tools a